Deerfield Management Company, L.P. (Series C) Aurinia Pharmaceuticals Inc. Put Options Transaction History

Deerfield Management Company, L.P. (Series C)

$5.38 Billion
Q3 2024

Put Options

2 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$17.78 - $33.08 $7.56 Million - $14.1 Million	-425,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$10.93 - $23.55 $4.65 Million - $10 Million	425,300 New	425,300 $9.41 Million

Others Institutions Holding AUPH

# of Institutions

209

Shares Held

58.7M

Call Options Held

1.14M

Put Options Held

1.51M

Black Rock Inc. New York, NY

9.27M
Shares

$75.3 Million
0.0% of portfolio
Armistice Capital, LLC New York, NY

8.2M
Shares

$66.6 Million
1.0% of portfolio
Tang Capital Management LLC San Diego, CA

7.23M
Shares

$58.7 Million
4.52% of portfolio
Nea Management Company, LLC Timonium, MD

3.97M
Shares

$32.2 Million
2.22% of portfolio
State Street Corp Boston, MA

2.95M
Shares

$23.9 Million
0.0% of portfolio

View Full List

About Aurinia Pharmaceuticals Inc.

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.15B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

More about AUPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deerfield Management Company, L.P. (Series C), based on Form 13F filings with the SEC.

News

Stay updated on Deerfield Management Company, L.P. (Series C) with notifications on news.

Account